A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
oleh: Federico Meconi, Ida Provenzano, Daniela Nasso, Benedetta Mariotti, Livio Pupo, Roberto Secchi, Raffaella Cerretti, Anemona Lucia, William Arcese, Maria Cantonetti
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2020-08-01 |
Deskripsi
Abstract Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choice in treating metachronous T‐cell NHL.